Literature DB >> 9327476

Case-control studies in clinical research: mechanism and prevention of selection bias.

A Morabia1.   

Abstract

The mechanism by which selection bias occurs in case-control studies is explained to an audience of clinicians using a simple conceptual framework and a graphical presentation. A case-control study consists in comparing the frequency of exposure in a group of subjects having the studied disease (the cases) relative to another group free of that disease (the controls). Cases and controls can be thought of as arising from a hypothetical cohort study. Thus, enrolled cases are a fraction F1 of the exposed who developed the disease plus a fraction F3 of the unexposed who developed the disease during a given period. Similarly, enrolled controls are a fraction F2 of the exposed who did not develop disease plus a fraction F4 of the unexposed who did not develop the disease. A selection process is inherent to the design of case-control studies but it leads to selection bias only when the ratio of F1 x F4/F2 x F3 is not equal to unity. Examples demonstrate the implication of sampling fractions for designing and interpreting case-control studies performed in clinical settings.

Mesh:

Year:  1997        PMID: 9327476     DOI: 10.1006/pmed.1997.0189

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  4 in total

1.  Longest held occupation in a lifetime and risk of disability in activities of daily living.

Authors:  C Y Li; S C Wu; S W Wen
Journal:  Occup Environ Med       Date:  2000-08       Impact factor: 4.402

2.  Reliability and validity of the brief insomnia questionnaire in the America insomnia survey.

Authors:  Ronald C Kessler; Catherine Coulouvrat; Goeran Hajak; Matthew D Lakoma; Thomas Roth; Nancy Sampson; Victoria Shahly; Alicia Shillington; Judith J Stephenson; James K Walsh; Gary K Zammit
Journal:  Sleep       Date:  2010-11       Impact factor: 5.849

Review 3.  Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation.

Authors:  Ernesto S Nakayasu; Marina Gritsenko; Paul D Piehowski; Yuqian Gao; Daniel J Orton; Athena A Schepmoes; Thomas L Fillmore; Brigitte I Frohnert; Marian Rewers; Jeffrey P Krischer; Charles Ansong; Astrid M Suchy-Dicey; Carmella Evans-Molina; Wei-Jun Qian; Bobbie-Jo M Webb-Robertson; Thomas O Metz
Journal:  Nat Protoc       Date:  2021-07-09       Impact factor: 17.021

4.  The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.

Authors:  Tingting Men; Cuicui Yu; Dan Wang; Fang Liu; Jingjing Li; Xiaoying Qi; Chunhua Yang; Wenguo Jiang; Xiaodan Wei; Xuri Li; Bin Wang; Jia Mi; Geng Tian
Journal:  Oncotarget       Date:  2017-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.